全文获取类型
收费全文 | 3348篇 |
免费 | 258篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 105篇 |
妇产科学 | 76篇 |
基础医学 | 540篇 |
口腔科学 | 68篇 |
临床医学 | 350篇 |
内科学 | 684篇 |
皮肤病学 | 136篇 |
神经病学 | 422篇 |
特种医学 | 81篇 |
外科学 | 273篇 |
综合类 | 11篇 |
一般理论 | 1篇 |
预防医学 | 275篇 |
眼科学 | 46篇 |
药学 | 237篇 |
中国医学 | 5篇 |
肿瘤学 | 265篇 |
出版年
2024年 | 6篇 |
2023年 | 62篇 |
2022年 | 89篇 |
2021年 | 185篇 |
2020年 | 102篇 |
2019年 | 149篇 |
2018年 | 137篇 |
2017年 | 99篇 |
2016年 | 108篇 |
2015年 | 134篇 |
2014年 | 160篇 |
2013年 | 170篇 |
2012年 | 289篇 |
2011年 | 284篇 |
2010年 | 145篇 |
2009年 | 129篇 |
2008年 | 189篇 |
2007年 | 170篇 |
2006年 | 152篇 |
2005年 | 180篇 |
2004年 | 119篇 |
2003年 | 147篇 |
2002年 | 113篇 |
2001年 | 44篇 |
2000年 | 30篇 |
1999年 | 26篇 |
1998年 | 18篇 |
1997年 | 20篇 |
1996年 | 19篇 |
1995年 | 14篇 |
1994年 | 20篇 |
1993年 | 10篇 |
1992年 | 12篇 |
1991年 | 10篇 |
1990年 | 15篇 |
1989年 | 6篇 |
1988年 | 8篇 |
1987年 | 6篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 4篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1980年 | 3篇 |
1978年 | 3篇 |
1971年 | 2篇 |
1931年 | 2篇 |
1930年 | 2篇 |
1929年 | 5篇 |
1903年 | 1篇 |
排序方式: 共有3617条查询结果,搜索用时 15 毫秒
41.
Evandro Luís Niero Bianca Rocha-Sales Camila Lauand Beatriz Araujo Cortez Marcelo Medina de Souza Paula Rezende-Teixeira Marcel Shiniti Urabayashi Adam Arai Martens Jorge Henrique Neves Gláucia Maria Machado-Santelli 《Journal of experimental & clinical cancer research : CR》2014,33(1):37
Some cancers like melanoma and pancreatic and ovarian cancers, for example, commonly display resistance to chemotherapy, and this is the major obstacle to a better prognosis of patients. Frequently, literature presents studies in monolayer cell cultures, 3D cell cultures or in vivo studies, but rarely the same work compares results of drug resistance in different models. Several of these works are presented in this review and show that usually cells in 3D culture are more resistant to drugs than monolayer cultured cells due to different mechanisms. Searching for new strategies to sensitize different tumors to chemotherapy, many methods have been studied to understand the mechanisms whereby cancer cells acquire drug resistance. These methods have been strongly advanced along the years and therapies using different drugs have been increasingly proposed to induce cell death in resistant cells of different cancers. Recently, cancer stem cells (CSCs) have been extensively studied because they would be the only cells capable of sustaining tumorigenesis. It is believed that the resistance of CSCs to currently used chemotherapeutics is a major contributing factor in cancer recurrence and later metastasis development. This review aims to appraise the experimental progress in the study of acquired drug resistance of cancer cells in different models as well as to understand the role of CSCs as the major contributing factor in cancer recurrence and metastasis development, describing how CSCs can be identified and isolated. 相似文献
42.
43.
44.
45.
46.
47.
48.
49.
Saidy Vásconez Noguera Evelyn Patrícia Sánchez Espinoza Marina Farrel Côrtes Izabel Cristina Vilela Oshiro Fernanda de Sousa Spadão Laura Maria Brasileiro Brandão Ana Natiele da Silva Barros Sibeli Costa Bianca Leal de Almeida Paula Gemignani Soriano Alessandra Grassi Salles Mirian Elizabete Marques Escorcio Cristina Madeira Barretti Fernanda Spadotto Baptista Glaura Souza Alvarenga Igor Marinho Leila Suemi Harima Letaif Ho Ye Li Silvia Figueiredo Costa 《American journal of infection control》2021,49(4):512-515
50.
Ariel R. Green Cynthia M. Boyd Kathy S. Gleason Leslie Wright Courtney R. Kraus Ruth Bedoy Bianca Sanchez Jonathan Norton Orla C. Sheehan Jennifer L. Wolff Emily Reeve Matthew L. Maciejewski Linda A. Weffald Elizabeth A. Bayliss 《Journal of general internal medicine》2020,35(12):3556
BackgroundPatients with dementia and multiple chronic conditions (MCC) frequently experience polypharmacy, increasing their risk of adverse drug events.ObjectivesTo elucidate patient, family, and physician perspectives on medication discontinuation and recommended language for deprescribing discussions in order to inform an intervention to increase awareness of deprescribing among individuals with dementia and MCC, family caregivers and primary care physicians. We also explored participant views on culturally competent approaches to deprescribing.DesignQualitative approach based on semi-structured interviews with patients, caregivers, and physicians.ParticipantsPatients aged ≥ 65 years with claims-based diagnosis of dementia, ≥ 1 additional chronic condition, and ≥ 5 chronic medications were recruited from an integrated delivery system in Colorado and an academic medical center in Maryland. We included caregivers when present or if patients were unable to participate due to severe cognitive impairment. Physicians were recruited within the same systems and through snowball sampling, targeting areas with large African American and Hispanic populations.ApproachWe used constant comparison to identify and compare themes between patients, caregivers, and physicians.Key ResultsWe conducted interviews with 17 patients, 16 caregivers, and 16 physicians. All groups said it was important to earn trust before deprescribing, frame deprescribing as routine and positive, align deprescribing with goals of dementia care, and respect caregivers’ expertise. As in other areas of medicine, racial, ethnic, and language concordance was important to patients and caregivers from minority cultural backgrounds. Participants favored direct-to-patient educational materials, support from pharmacists and other team members, and close follow-up during deprescribing. Patients and caregivers favored language that explained deprescribing in terms of altered physiology with aging. Physicians desired communication tips addressing specific clinical situations.ConclusionsCulturally sensitive communication within a trusted patient-physician relationship supplemented by pharmacists, and language tailored to specific clinical situations may support deprescribing in primary care for patients with dementia and MCC.Electronic supplementary materialThe online version of this article (10.1007/s11606-020-06063-y) contains supplementary material, which is available to authorized users.KEY WORDS: deprescribing, patient-physician communication, dementia 相似文献